Nephros, Inc. (NEPH) Stock Overview
Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Nephros, Inc. (NEPH)
Key Financials
Key Financials
Market Cap
38.6M
P/E Ratio
48.36
EPS (TTM)
$0.07
ROE
0.08%
NEPH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Nephros, Inc. (NASDAQ: NEPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Nephros, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NEPH on the NASDAQ shows an RSI of 53.84, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.29 for the NASDAQ listing.
Key metrics behind Nephros, Inc.'s NASDAQ-traded stock include a P/E ratio of 48.36 and a market capitalization of 38.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NEPH on the NASDAQ.